 - More than 26 weeks, with a CDAI 150 at Visit Week 26 and all subsequent visits, and subject is between Week 26 and 52 within 4 weeks 28 days of site activation e.g. Subject with CDAI 249 at week 26 and who is at week 38 at the time of sites activation for RHB-104-04 has a 4-week window to be enrolled in the open label study via the Optional Screening Visit 